Dan Kuritzkes, MD
Director of AIDS Research
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

 

Daniel R. Kuritzkes, MD received his BS and MS degrees in Molecular Biophysics and Biochemistry from Yale University in 1978, and his MD from Harvard Medical School in 1983. He completed his clinical and research training in internal medicine and infectious disease at Massachusetts General Hospital, and was a visiting scientist at the Whitehead Institute for Biomedical Research before joining the faculty at the University of Colorado Health Sciences Center in 1990. Dr. Kuritzkes returned to Harvard Medical School in 2002, where he is Professor of Medicine and Director of AIDS Research, Brigham & Women's Hospital. He is also Head of the Section of Retroviral Therapeutics for the Harvard Division of AIDS, and Principal Investigator of the Harvard AIDS Clinical Trials Unit.

Dr. Kuritzkes has authored nearly 200 articles, chapters, and reviews on antiretroviral therapy and on the problem of drug resistance in HIV-1 infection. He has chaired several multicenter studies of HIV therapy and is a member of the International AIDS Society-USA panel on HIV drug resistance and resistance testing. He has served on numerous NIH committees and editorial boards, and currently chairs the AIDS Clinical Trials Group Scientific Agenda Steering Committee, in addition to serving as Vice Chair of the ACTG Executive Committee. Dr. Kuritzkes also is an Associate Editor of the Journal of Infectious Diseases and Chair, Board of Directors of the HIV Medicine Association. His research interests focus on antiretroviral therapy and drug resistance.